感染核医学成像简史
本文回顾了近50年核医学在感染诊断中的应用历程,从柠檬酸镓Ga 67到体外标记白细胞显像,再到18F-氟脱氧葡萄糖(18F-FDG)。这些显像剂的摄取基于宿主对感染的反应而非感染本身,研究者仍在致力于开发感染特异性显像剂。
要点
- 柠檬酸镓Ga 67是最早用于感染诊断的放射性核素之一,因成像特性不佳、缺乏特异性及给药至显像间隔長(2-3天)而促使寻找替代品。
- 体外标记白细胞显像仍是感染成像的重要手段,但存在显著缺点,体内标记方法开发仅取得有限成功。
- 18F-FDG已成为肌肉骨骼和心血管感染、结节病及发热待查的有价值显像剂,但其摄取基于宿主反应而非感染本身。
核心结论
- 核医学显像剂如柠檬酸镓Ga 67、标记白细胞和18F-FDG的摄取基于宿主对感染的反应而非感染本身,研究者继续专注于开发感染特异性核医学显像剂。
研究设计与样本
- 本文为综述,回顾了近50年核医学在感染诊断中的应用历史。
主要发现
- 柠檬酸镓Ga 67因成像特性不佳、缺乏特异性及给药至显像间隔2-3天而促使寻找替代品;目前主要用于鉴别急性肾小管坏死与间质性肾炎,以及作为结节病、椎间盘炎和发热待查的替代选择(当18F-FDG不可用时)。
- 20世纪80年代中期体外标记白细胞技术获批是核医学感染成像的重大进展,标记白细胞显像仍起重要作用,但存在显著缺点,体内标记方法开发仅取得有限成功。
- 过去20年18F-FDG已成为肌肉骨骼和心血管感染、结节病及发热待查的有价值显像剂。
- 既往开发感染特异性显像剂(包括放射性标记抗生素和维生素)的尝试因结果不佳和/或缺乏可用性而受限。
局限性
- 柠檬酸镓Ga 67成像特性不佳且缺乏特异性。
- 体外标记白细胞显像存在显著缺点。
- 体内白细胞标记方法开发仅取得有限成功。
- 既往感染特异性显像剂(放射性标记抗生素和维生素)开发因结果不佳和/或缺乏可用性而受限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
For nearly 50 years, nuclear medicine has played an important role in the diagnosis of infection. Gallium citrate Ga 67 was one of the first, if not the first, radionuclide used for this purpose. Unfavorable imaging characteristics, a lack of specificity, and the long interval (2-3 days) between administration and imaging spurred the search for alternatives. At the present time, gallium 67 citrate is used primarily for differentiating acute tubular necrosis from interstitial nephritis and as an alternative for indications including sarcoid, spondylodiscitis, and fever of unknown origin, when 18F-fluorodeoxyglucose (18F-FDG) is not available. The approval, in the mid-1980s, of techniques for in vitro labeling of leukocytes with indium-111 and technetium-99m that subsequently migrate to foci of infection was a significant advance in nuclear medicine imaging of infection and labeled leukocyte imaging still plays an important role in imaging of infection. There are significant disadvantages to in vitro labeled leukocyte imaging. Unfortunately, efforts devoted to developing in vivo leukocyte labeling methods have met with only limited success. Over the past 20 years 18F-FDG has established itself as a valuable imaging agent for musculoskeletal and cardiovascular infections, as well as sarcoidosis and fever of unknown origin. As useful as these agents are, their uptake is based on the host response to infection, not infection itself. Previous attempts at developing infection-specific agents, including radiolabeled antibiotics and vitamins, were limited by poor results and/or lack of availability, so investigators continue to focus on developing infection-specific nuclear medicine imaging agents.
引用
- Palestro CJ. A Brief History of Nuclear Medicine Imaging of Infection. J Infect Dis. 2023. PMID: 37788498. doi:10.1093/infdis/jiac466
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。